Literature DB >> 17452236

Mutations in bile salt export pump (ABCB11) in two children with progressive familial intrahepatic cholestasis and cholangiocarcinoma.

A O Scheimann1, S S Strautnieks, A S Knisely, J A Byrne, R J Thompson, M J Finegold.   

Abstract

Fatal peripheral cholangiocarcinoma developed in 2 girls with progressive familial intrahepatic cholestasis, ABCB11 mutations, and absent bile salt export pump (BSEP) expression. BSEP deficiency may cause cholangiocarcinoma through bile-composition shifts or bile-acid damage within cells capable of hepatocytic/cholangiocytic differentiation. This observation suggests the need for hepatobiliary-malignancy surveillance and early consideration for liver transplantation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17452236     DOI: 10.1016/j.jpeds.2007.02.030

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  34 in total

1.  Morphologic findings in progressive familial intrahepatic cholestasis 2 (PFIC2): correlation with genetic and immunohistochemical studies.

Authors:  Kimberley Evason; Kevin E Bove; Milton J Finegold; A S Knisely; Sue Rhee; Philip Rosenthal; Alexander G Miethke; Saul J Karpen; Linda D Ferrell; Grace E Kim
Journal:  Am J Surg Pathol       Date:  2011-05       Impact factor: 6.394

Review 2.  Liver transplantation and the management of progressive familial intrahepatic cholestasis in children.

Authors:  Ashley Mehl; Humberto Bohorquez; Maria-Stella Serrano; Gretchen Galliano; Trevor W Reichman
Journal:  World J Transplant       Date:  2016-06-24

3.  Bile acids via FXR initiate the expression of major transporters involved in the enterohepatic circulation of bile acids in newborn mice.

Authors:  Julia Yue Cui; Lauren M Aleksunes; Yuji Tanaka; Zidong Donna Fu; Ying Guo; Grace Liejun Guo; Hong Lu; Xiao-Bo Zhong; Curtis D Klaassen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-01-19       Impact factor: 4.052

Review 4.  Progressive familial intrahepatic cholestasis.

Authors:  Anshu Srivastava
Journal:  J Clin Exp Hepatol       Date:  2013-11-23

Review 5.  Genetic and environmental determinants of risk for cholangiocarcinoma in Thailand.

Authors:  Masanao Miwa; Satoshi Honjo; Gyokukou You; Masakazu Tanaka; Kazuhiko Uchida; Petcharin Srivatanakul; Thiravud Khuhaprema; Watcharin Loilome; Anchalee Techasen; Chaisiri Wongkham; Temduang Limpaiboon; Puangrat Yongvanit; Sopit Wongkham
Journal:  World J Gastrointest Pathophysiol       Date:  2014-11-15

6.  Analysis of gene mutations in children with cholestasis of undefined etiology.

Authors:  Ursula Matte; Reena Mourya; Alexander Miethke; Cong Liu; Gregory Kauffmann; Katie Moyer; Kejian Zhang; Jorge A Bezerra
Journal:  J Pediatr Gastroenterol Nutr       Date:  2010-10       Impact factor: 2.839

7.  Hydrophilic bile acids prevent liver damage caused by lack of biliary phospholipid in Mdr2-/- mice.

Authors:  Renxue Wang; Jonathan A Sheps; Lin Liu; Jun Han; Patrick S K Chen; Jason Lamontagne; Peter D Wilson; Ian Welch; Christoph H Borchers; Victor Ling
Journal:  J Lipid Res       Date:  2018-11-11       Impact factor: 5.922

8.  Bile Acid Receptors and Liver Cancer.

Authors:  Xichun Wang; Xianghui Fu; Carl Van Ness; Zhipeng Meng; Xiaoxiao Ma; Wendong Huang
Journal:  Curr Pathobiol Rep       Date:  2012-12-21

9.  Pancreatic adenocarcinoma in type 2 progressive familial intrahepatic cholestasis.

Authors:  Lee M Bass; Deepa Patil; M Sambasiva Rao; Richard M Green; Peter F Whitington
Journal:  BMC Gastroenterol       Date:  2010-03-13       Impact factor: 3.067

10.  Bile acids as endogenous etiologic agents in gastrointestinal cancer.

Authors:  Harris Bernstein; Carol Bernstein; Claire M Payne; Katerina Dvorak
Journal:  World J Gastroenterol       Date:  2009-07-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.